CYP2D6 genotype in psychiatric patients:: Impact on haloperidol metabolism.

被引：0
|
作者：
Schmider, J [1 ]
Sachse, C [1 ]
Walter, S [1 ]
Filler, D [1 ]
Kaiser, R [1 ]
Roots, I [1 ]
Brockmöller, J [1 ]
机构：
[1] Humboldt Univ, Univ Clin Charite, Inst Clin Pharmacol, Berlin, Germany
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1998年 / 63卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII51
引用
收藏
页码：185 / 185
页数：1
相关论文
共 50 条
  • [1] Cytochrome P450-26 (CYP2D6) genotype: Relationship with clozapine and haloperidol metabolism.
    deLeon, J
    Wedlund, P
    Ehlers, R
    Josiassen, R
    Cooper, T
    Simpson, G
    BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 311 - 311
  • [2] Metabolism of desipramine in Japanese psychiatric patients:: The impact of CYP2D6 genotype on the hydroxylation of desipramine
    Shimoda, K
    Morita, S
    Hirokane, G
    Yokono, A
    Someya, T
    Takahashi, S
    PHARMACOLOGY & TOXICOLOGY, 2000, 86 (06): : 245 - 249
  • [3] Effect of CYP2D6 genotypes on the metabolism of haloperidol in a Japanese psychiatric population
    Someya, T
    Shimoda, K
    Suzuki, Y
    Sato, S
    Kawashima, Y
    Hirokane, G
    Morita, S
    Yokono, A
    Takahashi, S
    NEUROPSYCHOPHARMACOLOGY, 2003, 28 (08) : 1501 - 1505
  • [4] Effect of CYP2D6 Genotypes on the Metabolism of Haloperidol in a Japanese Psychiatric Population
    Toshiyuki Someya
    Kazutaka Shimoda
    Yutaro Suzuki
    Satoshi Sato
    Yoshiaki Kawashima
    Genta Hirokane
    Sachiyo Morita
    Aya Yokono
    Saburo Takahashi
    Neuropsychopharmacology, 2003, 28 : 1501 - 1505
  • [5] Metabolism of antipsychotics and CYP2D6 genotype
    Schmider, J
    Walter, S
    Sachse, C
    Bauer, S
    Müller-Oerlinghausen, B
    Roots, I
    Brockmöller, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R459 - R459
  • [6] CYP2D6 genotype and plasma levels of haloperidol and reduced haloperidol in Japanese
    Kondo, T
    Suzuki, A
    Mihara, K
    Yasui, N
    Kaneko, S
    MOLECULAR MEDICINE: NOVEL FINDINGS OF GENE DIAGNOSIS, REGULATION OF GENE EXPRESSION, AND GENE THERAPY, 1999, 1172 : 81 - 86
  • [7] CYP2D6 genotype polymorphism: tailored treatments in psychiatric patients
    La Montagna, M.
    Stella, E.
    Seripa, D.
    Miscio, G.
    Rinaldi, A.
    Bellomo, A.
    Lozupone, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S167 - S167
  • [8] CYP2D6 Genotype Dependent Oxycodone Metabolism in Postoperative Patients
    Stamer, Ulrike M.
    Zhang, Lan
    Book, Malte
    Lehmann, Lutz E.
    Stuber, Frank
    Musshoff, Frank
    PLOS ONE, 2013, 8 (03):
  • [9] A novel CYP2D6 scoring system for the prediction of CYP2D6 activity: Application to tamoxifen metabolism.
    Borges, S.
    Li, L.
    Robarge, J.
    Nguyen, A.
    Azzouz, F.
    Desta, Z.
    Skaar, T.
    Flockhart, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S67 - S67
  • [10] Effect of the CYP2D6 genotype on prolactin concentration in schizophrenic patients treated with haloperidol
    Yasui-Furukori, N
    Kondo, T
    Suzuki, A
    Mihara, K
    Tokinaga, N
    Inoue, Y
    Otani, K
    Kaneko, S
    SCHIZOPHRENIA RESEARCH, 2001, 52 (1-2) : 139 - 142
12345